Tatiani Oliveira Fereguetti
YOU?
Author Swipe
View article: P-1981. MMCD score for predicting kidney replacement therapy in hospitalized patients with COVID-19 from 2020 to 2022
P-1981. MMCD score for predicting kidney replacement therapy in hospitalized patients with COVID-19 from 2020 to 2022 Open
Background Acute kidney injury (AKI) requiring kidney replacement therapy (KRT) in its most severe forms is a significant complication of patients with COVID-19. The development of a risk score to predict KRT requirement could optimize hea…
View article: Potential and limitations of machine meta-learning (ensemble) methods for predicting COVID-19 mortality in a large inhospital Brazilian dataset
Potential and limitations of machine meta-learning (ensemble) methods for predicting COVID-19 mortality in a large inhospital Brazilian dataset Open
The majority of early prediction scores and methods to predict COVID-19 mortality are bound by methodological flaws and technological limitations (e.g., the use of a single prediction model). Our aim is to provide a thorough comparative st…
View article: Effectiveness, Explainability and Reliability of Machine Meta-Learning Methods for Predicting Mortality in Patients with COVID-19: Results of the Brazilian COVID-19 Registry
Effectiveness, Explainability and Reliability of Machine Meta-Learning Methods for Predicting Mortality in Patients with COVID-19: Results of the Brazilian COVID-19 Registry Open
Objective To provide a thorough comparative study among state-of-the-art machine learning methods and statistical methods for determining in-hospital mortality in COVID-19 patients using data upon hospital admission; to study the reliabili…
View article: Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes
Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes Open
Chagas disease (CD) continues to be a major public health burden in Latina America. Information on the interplay between COVID-19 and CD is lacking. Our aim was to assess clinical characteristics and in-hospital outcomes of patients with C…
View article: Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes
Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes Open
Chagas disease (CD) continues to be a major public health burden in Latina America. Information on the interplay between COVID-19 and CD is lacking. Our aim was to assess clinical characteristics and in-hospital outcomes of patients with C…
View article: Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes: results from the Brazilian COVID-19 Registry
Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes: results from the Brazilian COVID-19 Registry Open
Objective Chagas disease (CD) continues to be a major public health burden in Latina America, where co-infection with SARS-CoV-2 can occur. However, information on the interplay between COVID-19 and Chagas disease is lacking. Our aim was t…
View article: ABC<sub>2</sub>-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores
ABC<sub>2</sub>-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores Open
Objective To develop and validate a rapid scoring system at hospital admission for predicting in-hospital mortality in patients hospitalized with coronavirus disease 19 (COVID-19), and to compare this score with other existing ones. Design…
View article: Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry
Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry Open
This study reveals the characteristics and in-hospital outcomes of hospitalized patients with confirmed COVID-19 in Brazil. Certain easily assessed parameters at hospital admission were independently associated with a higher risk of death.…
View article: The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis
The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis Open
These results clearly demonstrate a low spontaneous cure rate following no-treatment or placebo use, confirming that this strategy for the control group in CL studies expose patients to greater morbidity, especially for CL caused by L. bra…